|
PROCYTE TO REPORT THIRD QUARTER 2004 FINANCIAL
RESULTS ON TUESDAY, NOVEMBER 2, 2004
Redmond, Wash.
— October 22, 2004 — ProCyte Corporation (OTCBB: PRCY.OB)
is scheduled to report financial results for the third quarter 2004 on
Tuesday, November 2 before the market opens.
ProCyte will hold
a conference call at 4:30 p.m. Eastern Time on Tuesday, November
2, 2004 to discuss the Company’s third quarter 2004 results. To
participate in the conference call, dial 800-260-1153 (confirmation code
87768#) approximately 5 minutes prior to the scheduled start time. If
you are unable to participate, a replay of the call will be available
from 7:30 p.m. Eastern Time on Tuesday, November 2nd until midnight on
Saturday, November 6th, by dialing 800-294-1193 and telling the operator
that you want to listen to the ProCyte playback.
ProCyte Corporation
develops and markets products based on its patented, clinically proven
Copper Peptide technology for skin health, hair care and wound care. The
Company sells directly to dermatologists, plastic and cosmetic surgeons,
spas and salons and through licenses with strategic partners into the
consumer market, including its long-term worldwide license agreement
with Neutrogena®, a Johnson & Johnson company. ProCyte brands
include Neova ®,
VitalCopper™,
Simple Solutions ®
and AquaSanté®
Skin Care products; Complex Cu3®
Post-Procedure Skin Care; GraftCyte®
Hair Transplant Care; and Tricomin®
Advanced Care for Thinning Hair. The Company also has the exclusive
distribution rights for Cutanix Corporation’s Quadrinone®
technology in the U.S., Canada and Puerto Rico.
Additional information is available by visiting the Company’s website at
www.procyte.com.
###
This release may contain forward-looking statements relating to the
research, development, commercialization, production, marketing and
distribution of the Company's products and future operating results,
which are subject to certain risks and uncertainties that could cause
actual results to differ materially from those projected.
The
words “believe,” “expect,” “intend,” “anticipate,” variations of such
words, and similar expressions
identify forward-looking statements, but their absence does not mean
that the statement is not forward-looking. These statements are not
guarantees of future performance and are subject to certain risks,
uncertainties and assumptions that are difficult to predict. Factors
that could affect the Company’s actual results include its ability to
develop, commercialize and produce new products; the market acceptance
of existing and potential future products; the availability, cost and
timely delivery of materials and services from and performance of
third-party suppliers, manufacturers, distributors, licensees and other
collaborative partners; the satisfaction of regulatory requirements, and
the receipt, timing, terms and conditions of required regulatory
approvals. Reference is made to the Company’s Annual Report on Form
10-K for the year ended December 31, 2003 and its latest quarterly
report on Form 10Q filed with the Securities and Exchange Commission for
a more detailed description of such factors. Readers are cautioned not
to place undue reliance on these forward-looking statements, which speak
only as of the date of this release. The Company undertakes no
obligation to publicly update any forward-looking statement to reflect
new information, events or circumstances after the date of this release
or to reflect the occurrence of unanticipated events.
|
